![cover image](https://wikiwandv2-19431.kxcdn.com/_next/image?url=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4f/Suntinorexton.svg/640px-Suntinorexton.svg.png&w=640&q=50)
Suntinorexton
Chemical compound / From Wikipedia, the free encyclopedia
Suntinorexton (INNTooltip International Nonproprietary Name) is an experimental orexin receptor agonist.[1] It acts as a selective agonist of the orexin OX2 receptor and was described in 2019 in a patent by Takeda Pharmaceutical Company.[2]
Quick Facts Identifiers, CAS Number ...
![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
UNII | |
Chemical and physical data | |
Formula | C23H28F2N2O4S |
Molar mass | 466.54 g·mol−1 |
3D model (JSmol) | |
| |
|
Close